Multi-accredited Webinar Series: Earn Free CE Credit!

Session I | Saturday, November 14, 2020

12:00 pm – 2:15 pm ET


  • Trending Now: Hot Topics in Obesity 2020
  • Obesity Pharmacotherapy – Important Considerations for Treatment Selection
  • Individualizing Obesity Management: Considering Lifestyle Changes, Surgery, and Pharmacotherapy
  • LIVE Question & Answer

Session II | Saturday, November 21, 2020

12:00 pm – 2:15 pm ET


  • Patient Perspective: Sharing the Decisions to Improve Outcomes
  • Rapid-fire Talks in Obesity – Featuring: Adipose Tissue Crosstalk and Individualizing Obesity Care Using Staging Systems and Phenotyping
  • Treating Children and Adolescents with Obesity
  • LIVE Interactive Case Challenges
  • LIVE Question & Answer

Series Overview

Obesity is a chronic condition that is becoming increasingly common in the United States and is associated with substantial risks of morbidity and mortality. It is also a risk factor for some of the leading causes of preventable death, including heart disease, stroke, type 2 diabetes mellitus, and certain cancers. With prevalence continuing to escalate, it is predicted that 1 in 2 Americans will have obesity by 2030—with women and minorities most at risk in the coming years. Currently, underdiagnosis and undertreatment of obesity are frequent due to shortcomings in patient evaluation; uncertainty regarding approaches that support good adherence to behavioral and lifestyle modifications; and lack of thorough knowledge concerning the efficacy and safety of pharmacologic and surgical interventions. Patients with overweight and obesity often have multiple health concerns and may see several providers; therefore, a multidisciplinary management approach is required. The virtual Obesity Forum® 2020 is a 2-part multi-accredited webinar series that aims to provide health care professionals with guidance on the appropriate use of therapies and strategies for delivering individualized care to patients with overweight or obesity, including adolescents, via a multidisciplinary team. It will incorporate didactic presentations as well as the patient perspective, interactive case-based discussions, and live question-and-answer sessions.

CE Information

Target Audience

The intended audience for this activity is endocrinologists, family practice physicians, internists, nurse practitioners, physician assistants, pharmacists, and other health care professionals involved in the management of patients with overweight and obesity.

Series Learning Objectives

Upon successful completion of this activity, participants will be able to:

All Learners

  • Adopt a multidisciplinary team approach to facilitate comprehensive management of obesity and obesity-related manifestations.
  • Communicate with patients with obesity regarding their disease, concerns, and realistic treatment expectations to improve adherence to a comprehensive care plan.
  • Assess the latest clinical evidence regarding pharmacotherapy for the management of weight in adolescents with obesity.

Non-pharmacy Learners Only

  • Screen patients regularly for obesity and recommend follow-up care as appropriate.
  • Identify patients who may benefit from pharmacotherapy for weight management based on the latest clinical evidence regarding safety, efficacy, and long-term use.
  • Recommend bariatric surgery for patients with obesity as appropriate and provide comprehensive post-surgical care.

For more session-specific CE information, please visit the registration sites.